Moore JS - Search Results

1

Novel approach for simultaneous evaluation of cell phenotype, apoptosis, and cell cycle using multiparameter flow cytometry.

Douglas RS, Pletcher CH Jr, Nowell PC, Moore JS. Douglas RS, et al. Among authors: moore js. Cytometry. 1998 May 1;32(1):57-65. doi: 10.1002/(sici)1097-0320(19980501)32:1<57::aid-cyto8>3.0.co;2-c. Cytometry. 1998. PMID: 9581625 Free article.

2

Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia.

Friedman DF, Moore JS, Erikson J, Manz J, Goldman J, Nowell PC, Silberstein LE. Friedman DF, et al. Among authors: moore js. Blood. 1992 Nov 1;80(9):2287-97. Blood. 1992. PMID: 1421400 Free article.

3

Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets.

Fox FE, Capocasale RJ, Ford HC, Lamb RJ, Moore JS, Nowell PC. Fox FE, et al. Among authors: moore js. Lymphokine Cytokine Res. 1992 Dec;11(6):299-305. Lymphokine Cytokine Res. 1992. PMID: 1477183

4

Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens.

Silberstein LE, Jefferies LC, Goldman J, Friedman D, Moore JS, Nowell PC, Roelcke D, Pruzanski W, Roudier J, Silverman GJ. Silberstein LE, et al. Among authors: moore js. Blood. 1991 Nov 1;78(9):2372-86. Blood. 1991. PMID: 1657249 Free article.

5

Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease.

Goldberg H, Lusk E, Moore J, Nowell PC, Besa EC. Goldberg H, et al. Cancer Res. 1990 Nov 1;50(21):6876-81. Cancer Res. 1990. PMID: 2208156 Clinical Trial.

6

Ph-negative T cells in a patient with chronic myelogenous leukemia for twenty-eight years.

Nowell PC, Finan JB, Moore JS, Jackson L, Weiss A. Nowell PC, et al. Among authors: moore js. Leuk Res. 1989;13(11):1019-23. doi: 10.1016/0145-2126(89)90009-x. Leuk Res. 1989. PMID: 2558259

7

Defective T cell-mediated, isotype-specific immunoglobulin regulation in B cell chronic lymphocytic leukemia.

Moore JS, Prystowsky MB, Hoover RG, Besa EC, Nowell PC. Moore JS, et al. Blood. 1988 Apr;71(4):1012-20. Blood. 1988. PMID: 2895674 Free article.

8

Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells.

Ratajczak MZ, Kuczynski WI, Sokol DL, Moore JS, Pletcher CH Jr, Gewirtz AM. Ratajczak MZ, et al. Among authors: moore js. Blood. 1995 Sep 15;86(6):2161-7. Blood. 1995. PMID: 7545021 Free article.

9

Clinical heterogeneity reflects biologic diversity in chronic lymphocytic leukemia.

Moore JS, Friedman DF, Silberstein LE, Besa EC, Nowell PC. Moore JS, et al. Crit Rev Oncol Hematol. 1995 Aug;20(1-2):141-64. doi: 10.1016/1040-8428(94)00150-r. Crit Rev Oncol Hematol. 1995. PMID: 7576195 Free article. Review.

10

Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients.

Capocasale RJ, Lamb RJ, Vonderheid EC, Fox FE, Rook AH, Nowell PC, Moore JS. Capocasale RJ, et al. Among authors: moore js. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5501-5. doi: 10.1073/pnas.92.12.5501. Proc Natl Acad Sci U S A. 1995. PMID: 7777538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

582 results

Search Page

Filters